PALISADE CAPITAL MANAGEMENT, LP Q3 2019 Filing
Filed November 6, 2019
Portfolio Value
$3.3T
Holdings
425
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (425 positions)
| Stock | Value |
|---|---|
ABTABBOTT LABS | $238.0M |
GILDGILEAD SCIENCES INC | $231.0M |
—SYNCHRONOSS TECHNOLOGIES INC | $231.0M |
PEGPUBLIC SVC ENTERPRISE GRP IN | $230.0M |
FDXFEDEX CORP | $218.0M |
VTYVERINT SYS INC | $214.0M |
MTGMGIC INVT CORP WIS | $209.0M |
MOHMOLINA HEALTHCARE INC | $208.0M |
AVTRAVANTOR INC | $203.0M |
DEODIAGEO P L C | $202.0M |
YORWYORK WTR CO | $201.0M |
—TIVO CORP | $190.0M |
FEYECHFFIREEYE INC | $187.0M |
—RETROPHIN INC | $156.0M |
GEGENERAL ELECTRIC CO | $152.0M |
—CLOVIS ONCOLOGY INC | $139.0M |
SDCCQSMILEDIRECTCLUB INC | $139.0M |
—COLONY CAP INC NEW | $118.0M |
—DERMIRA INC | $74.0M |
CLVSEURCLOVIS ONCOLOGY INC | $71.0M |
CXCEMEX SAB DE CV | $39.0M |
—NANTHEALTH INC | $29.0M |
SENS1GBPSENSEONICS HLDGS INC | $25.0M |
—PALATIN TECHNOLOGIES INC | $17.0M |
—ENCORE CAP GROUP INC | $15.0M |
PreviousPage 5 of 5